Central administration of perfluorooctanoic acid inhibits cutaneous inflammation
about
Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alphaThe peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseasesEpidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA)Inhibition of Carrageenan-Induced Cutaneous Inflammation by PPAR Agonists Is Dependent on Hepatocyte-Specific Retinoid X ReceptorAlphaInverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in a large Appalachian population.Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema.Community exposure to perfluorooctanoate: relationships between serum levels and certain health parametersPerfluoroalkyl acids: a review of monitoring and toxicological findings.Rapid pain modulation with nuclear receptor ligands.A role for PPARα in the medial prefrontal cortex in formalin-evoked nociceptive responding in rats.Immunotoxicity of perfluorinated compounds: recent developments.Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in ratsPerfluorooctanoic acid induced-developmental cardiotoxicity: are peroxisome proliferator activated receptor α (PPARα) and bone morphorgenic protein 2 (BMP2) pathways involved?Effects of perfluorooctane sulfonate (PFOS) exposure on markers of inflammation in female B6C3F1 mice.
P2860
Q23914416-80F93D6E-1C2A-4C11-9A80-43663942A571Q24612698-CE8C1AA0-AB25-4152-9392-7419BBEBA9C9Q24632957-C9038C08-D287-45A9-A9A3-B4753E38F2B5Q28218456-8F6E3F10-1258-41A0-9925-7F57C44228D5Q30414928-60983771-7B93-4D06-99DC-437CE44974B9Q33618276-A93ACA86-352E-448F-A31B-F9E1B515D8A3Q34571004-39E9FB7D-8807-42F0-B634-3ED36BACD139Q34630884-BFE1757E-97B9-42F8-8833-8B7B2CC69881Q36964412-7021D0AA-4271-4888-A268-25F43CE83B16Q37637765-2025B039-0007-403F-9EAE-B4A630EA4D42Q37959888-FF8CB029-06CC-4B8B-8F68-8D475D8760A9Q41876697-3AB3C450-91AB-43A1-8D42-B5D24EF4106AQ42709872-C8A8FEB8-F427-49AC-A844-D3659C325C1FQ44249631-F0CA8D7E-AA51-4E8A-9FCF-077A06EF7B20
P2860
Central administration of perfluorooctanoic acid inhibits cutaneous inflammation
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Central administration of perfluorooctanoic acid inhibits cutaneous inflammation
@ast
Central administration of perfluorooctanoic acid inhibits cutaneous inflammation
@en
Central administration of perfluorooctanoic acid inhibits cutaneous inflammation
@nl
type
label
Central administration of perfluorooctanoic acid inhibits cutaneous inflammation
@ast
Central administration of perfluorooctanoic acid inhibits cutaneous inflammation
@en
Central administration of perfluorooctanoic acid inhibits cutaneous inflammation
@nl
prefLabel
Central administration of perfluorooctanoic acid inhibits cutaneous inflammation
@ast
Central administration of perfluorooctanoic acid inhibits cutaneous inflammation
@en
Central administration of perfluorooctanoic acid inhibits cutaneous inflammation
@nl
P2093
P1476
Central administration of perfluorooctanoic acid inhibits cutaneous inflammation
@en
P2093
P2888
P304
P356
10.1007/S00011-005-1350-0
P407
P577
2005-06-01T00:00:00Z
P6179
1027749634